Skip Navigation

Human Reproduction 2005 20(11):3257; doi:10.1093/humrep/dei171
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kol, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kol, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Letter to the editor

Luteal support post GnRH agonist trigger: do not stop too soon

Shahar Kol

IVF Unit, Rambam Medical Center, Haifa 31096, Israel

E-mail: skol{at}rambam.health.gov.il

Sir,

Humaidan et al. (2005)Go compared GnRH agonist (buserelin) and hCG triggers in a GnRH antagonist-based protocol. Luteal support was given for 12 days starting on the day following oocyte retrieval and stopping on the day of pregnancy test. The GnRH agonist group suffered a 79% early pregnancy loss.

Although recruitment for this study was complete by February 2004, recent studies have shown that triggering ovulation with a GnRH agonist causes complete luteolysis (Nevo et al., 2003Go), with the implication that luteal support is needed until week 9 of pregnancy (~2 weeks post luteal-placental shift). Without such support, a high rate of early pregnancy loss is inevitable.

References

Humaidan P, Ejdrup Bredkjaer H, Bungum L, Bungum M, Grondahl ML, Westergaard L and Yding Andersen C (2005) GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 20,1213–1220.[Abstract/Free Full Text]

Nevo O, Eldar-Geva T, Kol S and Itskovitz-Eldor J (2003) Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin. Fertil Steril 79,1123–1128.[CrossRef][ISI][Medline]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kol, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kol, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?